← Eichor
Condition: Congenital Myopathies Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Congenital Myopathies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammato
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06599411A Study to Check Liver Health in Boys With XLMTM, a Serious Genetic Muscle Condition
Phase N/A · 10 location(s) · Astellas Gene Therapies · NCT06581146The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients Wi
NA · 1 location(s) · Seoul National University Hospital · NCT06363357Dose Response of Exercise for Arthritis Management
NA · 1 location(s) · University of South Carolina · NCT06880653Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients
EARLY_Phase 1 · 1 location(s) · Shanghai Siponuoyin Biotechnology Co Ltd · NCT07188012Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT07021820phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
Phase N/A · 2 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT06366815Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT06227182Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Personalized Training for People With Rare Neuromuscular Disorders
NA · 5 location(s) · Oslo University Hospital · NCT06708468Clinical Trial Readiness for the Dystroglycanopathies
Phase N/A · 1 location(s) · Katherine Mathews · NCT00313677Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Phase N/A · 1 location(s) · Virginia Commonwealth University · NCT07700225To Evaluate the Efficiency and Results of Adding BFR to the Physical Therapy Program fo Managing Adolescents Presented W
NA · 1 location(s) · Assiut University · NCT07343752Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
Phase N/A · 3 location(s) · University of Florida · NCT01484678Natural History of Duchenne Muscular Dystrophy
Phase N/A · 15 location(s) · Genethon · NCT03882827A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.
Phase N/A · 1 location(s) · Radboud University Medical Center · NCT06132750Remote Assessments and Genetic Determinants of Myotonic Dystrophy
Phase N/A · 1 location(s) · University of Rochester · NCT07505342Telecare Psychosocial and Cognitive Intervention for Children and Adolescents With Limb-Girdle Muscular Dystrophy
NA · 1 location(s) · University of Deusto · NCT07711730KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
Phase 3 · 10 location(s) · Khondrion BV · NCT06451757The United Kingdom National Registry for Myotonic Dystrophy
Phase N/A · 1 location(s) · Newcastle University · NCT04003363Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06147414Biomarker Development for Muscular Dystrophies
Phase N/A · 5 location(s) · Massachusetts General Hospital · NCT05019625Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Phase N/A · 3 location(s) · Columbia University · NCT06839469Urinary Titin Biomarker in DMD
NA · 1 location(s) · Children's Hospital of Philadelphia · NCT07332013Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy
Phase N/A · 1 location(s) · Xi'an Jiaotong University · NCT06517498A Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
Phase N/A · 9 location(s) · ITF Therapeutics LLC · NCT07127978Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
EARLY_Phase 1 · 1 location(s) · Shanghai Jiao Tong University School of Medicine · NCT06900049FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
NA · 1 location(s) · Johns Hopkins University · NCT07521930Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT06093100
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.